Page last updated: 2024-12-05

succinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Succinamide is a white, crystalline solid with the formula C4H8N2O2. It is a dicarboxylic acid amide derived from succinic acid. Succinamide can be synthesized by the reaction of succinic anhydride with ammonia. It has been shown to exhibit anticonvulsant, anti-inflammatory, and analgesic activities in animal models. Succinamide is also a precursor to several other important compounds, including succinimide and succinyl chloride. Succinamide is studied for its potential therapeutic applications, particularly in the treatment of epilepsy and other neurological disorders. Its potential as a pharmaceutical agent is due to its ability to modulate neurotransmitter activity in the brain.'

Cross-References

ID SourceID
PubMed CID8036
CHEMBL ID541705
SCHEMBL ID36057
MeSH IDM0057160

Synonyms (35)

Synonym
F1995-0266
nsc8157
butanediamide
110-14-5
succindiamide
nsc-8157
succinic acid diamide
succinamide
succinic amide
succinamide, 98%
CHEMBL541705
AKOS002271138
EN300-83947
unii-y656f4n881
einecs 203-739-9
nsc 8157
y656f4n881 ,
FT-0631613
succinamide [mi]
t-152 (emulsifier)
BP-21127
SCHEMBL36057
DTXSID4059382
J-002384
LMFA08010026
succinic diamide
mfcd00008042
succinic acid diimide
SY057038
CS-0204735
succinamid
STL197950
H12055
Q27294303
AS-56329
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID429162Activation of human recombinant mitochondrial NADP-ME expressed in Escherichia coli BL21 assessed as residual enzyme activity by spectrophotometry in presence of fumarate2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Effects of structural analogues of the substrate and allosteric regulator of the human mitochondrial NAD(P)+-dependent malic enzyme.
AID429163Activation of human recombinant mitochondrial NADP-ME expressed in Escherichia coli BL21 assessed as residual enzyme activity by spectrophotometry in absence of fumarate2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Effects of structural analogues of the substrate and allosteric regulator of the human mitochondrial NAD(P)+-dependent malic enzyme.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.70)18.7374
1990's2 (5.41)18.2507
2000's12 (32.43)29.6817
2010's18 (48.65)24.3611
2020's4 (10.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.24 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index59.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (97.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]